Trial Information
Impact of Treatment Consultation Recordings on Cancer Patient Outcomes: A Prospective, Parallel, Randomized Controlled Trial
Inclusion Criteria:
- presenting with a primary diagnosis of non-recurrent or metastatic brain, or
neuroendocrine cancer
- 18 years of age or older
- able to read and communicate using the English language
- access to a computer to enable consultation playback
Exclusion Criteria:
- deemed by a treating clinician (or primary nurse for the treating clinician) to have
any severe psychiatric condition or cognitive dysfunction that precludes provision of
free and informed consent to participate
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Outcome Measure:
Change from Baseline in Control Preferences Scale at 1-week post-consultation
Outcome Description:
Subjective report of actual role played in decision making.
Outcome Time Frame:
1-week post-consultation
Safety Issue:
No
Principal Investigator
Thomas F Hack, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Manitoba
Authority:
Canada: Research Ethics Board
Study ID:
H2013:085
NCT ID:
NCT01866228
Start Date:
June 2013
Completion Date:
December 2015
Related Keywords:
- Brain Tumor
- Neuroendocrine Cancer
- Consultation Recording
- Brain Tumor
- Neuroendocrine Cancer
- Quality of Life
- Patient Satisfaction
- Brain Neoplasms